Hyperion DeFi, Inc.·Healthcare
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.
Healthcare
Medical - Devices
13
2025-07-02
2.58

Hyperion DeFi, Inc. (HYPD) Q1 2026 Earnings Call Transcript

Company Reports Record $8.8M Net Income and $19.5M Adjusted EBITDA ( 8 ) Treasury Exceeds 2.00M HYPE, 1.92M KNTQ, & 10.00M HPL Tokens as of May 11 (14) HYPD's Unique “Triple-Dip” HYPE Deployment Generated >3x Base Staking Income in Q1 Company Raises Adjusted Gross Profit (1) 2026 FY Guidance by ~20% DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today reported results for the first quarter ending March 31, 2026. “We are pleased to report continued scaling of our DeFi operating businesses, accretive balance sheet growth, and prudent cost management,” said Hyunsu Jung, CEO of Hyperion DeFi.

DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has closed its previously announced public offering of 2,777,778 shares of its common stock. The shares of common stock were sold to the public at a price of $3.60 per share. All of the shares of common stock sold in the public offering were sold by Hyperion DeFi. The gross proceeds to Hyperion DeFi from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $10.0 million. Hyperion DeFi has also granted the sole underwriter a 30-day option to purchase up to an additional 416,666 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.

DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced the pricing of a public offering of 2,777,778 shares of its common stock. The shares of common stock are being sold to the public at a price of $3.60 per share.

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in a proposed underwritten public offering. All of the shares of common stock and pre-funded warrants to be sold in the proposed offering are being offered by Hyperion DeFi. In addition, Hyperion DeFi intends to grant the sole underwriter a 30-day option to purchase up to an additional 15% of the total number of securities offered in the public offering. There can be no assurance as to whether or when the proposed public offering may be completed, or as to the actual size or terms of the proposed offering.

LAGUNA HILLS, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it will hold its earnings conference call and webcast for the first quarter ended March 31, 2026 on Thursday, May 14, 2026 at 8:00 a.m. Eastern Time.